A high-strength and low-modulus biomedical zirconium alloy and preparation method thereof
By controlling the elemental composition and heat treatment process of zirconium alloys, and combining selective laser melting technology, the thermal cycling problem of zirconium alloys in additive manufacturing has been solved, and high-strength zirconium alloys with low elastic modulus have been prepared. These alloys are suitable for biomedical implants, enabling personalized manufacturing of complex shapes and cost savings.
Patent Information
- Application Number
- CN202310063034.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-01-17
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2043-01-17
AI Technical Summary
Existing zirconium alloy additive manufacturing processes suffer from uneven thermal cycling during forming, which affects mechanical properties. Furthermore, the elastic modulus of traditional titanium alloys is higher than that of human bone, which may lead to a stress shielding effect of implants within the human body.
By strictly controlling the content of Nb, Ti, and Ta elements to form an infinite solid solution, and combining selective laser melting technology and heat treatment process, a high-strength zirconium alloy with low elastic modulus is prepared, which promotes the precipitation of ω phase and improves tensile strength.
The prepared zirconium alloy has higher tensile strength and lower elastic modulus, meeting the needs of biomedical implants, enabling personalized manufacturing of complex shapes, and reducing material costs.
Smart Images

Figure CN116103539B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of zirconium alloy materials and additive manufacturing, and in particular to an additive manufacturing method for high-strength and low-modulus biomedical zirconium alloy implants. Background Art
[0002] In recent years, with the development of human living standards and the improvement of medical standards, people's requirements for metal implant materials have also increased. Therefore, researchers have conducted in-depth research on implantable biological hard tissue materials. Metal implant materials must ensure good biocompatibility and high strength. At present, the commonly used implant metal materials are mostly stainless steel, titanium alloy, cobalt-chromium alloy, etc. Among them, titanium alloy has developed rapidly due to its good biocompatibility and mechanical properties. However, the elastic modulus of titanium alloy is much higher than that of human bones. Stainless steel and cobalt-chromium alloy will release metal ions in the human body, which will affect the human body. Zirconium alloy has good strength, plasticity, biocompatibility, and low magnetic susceptibility. It is currently widely used in nuclear energy, medical and other fields. It is an emerging biomedical material. As a new material in the biomedical field, it needs to meet various complex use environments and be able to withstand high tensile strength. At the same time, the shapes of medical implant parts are complex, and a new forming process method is needed.
[0003] At present, metal 3D printing, as a new manufacturing process, has changed the traditional subtractive processing method. It has the characteristics of short cycle, high flexibility, and fast response. Zirconium alloy is suitable for the field of metal additive manufacturing due to its good weldability, and the mechanical properties of the printed parts are at or even better than the level of forgings. The whole process is convenient and fast, which can save a lot of manpower and time. At the same time, the material utilization rate is high, and parts with complex shapes can be formed by layer-by-layer stacking. However, due to the uneven thermal cycle during the forming process, its mechanical properties will be affected.
[0004] In summary, there is an urgent need to study a zirconium alloy material with excellent mechanical properties. Based on the shortcomings of the current heat treatment process in effectively improving the mechanical properties of additively manufactured zirconium alloys, it is of great research value to develop a high-strength and low-modulus biomedical alloy material. Summary of the invention
[0005] The primary purpose of the present invention is to provide a high-strength and low-modulus biomedical zirconium alloy material.
[0006] Another object of the present invention is to provide a forming method of zirconium alloy by additive manufacturing.
[0007] Another object of the present invention is to provide a heat treatment process for controlling the precipitation of ω phase to improve the tensile strength of the sample.
[0008] In order to achieve the above object, the present invention adopts the following technical solutions:
[0009] A method for preparing a high-strength and low-modulus biomedical zirconium alloy comprises the following steps:
[0010] (1) Alloy composition design: In the present invention, by strictly controlling the content of each element and utilizing alloying, Nb and Ti elements form an infinite solid solution with Zr, thereby achieving solid solution strengthening, which can effectively improve the strength of the zirconium alloy. At the same time, Ta element has high biocompatibility and can be used as a human implant material. In addition, Nb, Ti, and Ta are all β-phase stabilizing elements, which can retain the high-temperature β-phase to room temperature, which is beneficial to reducing the elastic modulus of the alloy and improving the corrosion resistance and plasticity of the alloy. According to the binary phase diagram of zirconium alloy, the composition of the high-strength and low-modulus biomedical zirconium alloy is determined to be Zr 77.5at.%, Nb 10at.%, Ti 10at.%, and Ta 2.5at.%. According to the composition, the alloy components are prepared using sponge zirconium, sponge titanium, niobium block, and tantalum wire as raw materials;
[0011] (2) Alloy smelting: The Zr, Nb, Ti and Ta elements are mixed according to the content of step (1), and the alloy is smelted in a water-cooled copper crucible non-consumable vacuum arc furnace. After the smelting, the crucible is cooled by circulating cooling water at the bottom to prepare an alloy rod;
[0012] (3) Atomization powder making: The alloy rod is atomized by a rotating electrode induction gas atomization device to prepare zirconium alloy powder and sieve it to obtain a spherical powder with a particle size range suitable for additive manufacturing;
[0013] (4) Additive manufacturing: Selective laser melting equipment is used for additive manufacturing to obtain medical zirconium alloy; key molding process parameters are laser power: 180-250W, scanning speed: 600-1100mm / s, scanning spacing 0.06-0.11mm, scanning layer thickness 0.3mm, and oxygen content in the molding process is controlled at 400-600ppm;
[0014] (5) Heat treatment: The Zr-10Nb-10Ti-2.5Ta zirconium alloy formed by selective laser melting is kept at 500-700°C for 1-4 hours to obtain a high-strength and low-modulus biomedical zirconium alloy.
[0015] Preferably, the vacuum degree in the furnace in step (2) is 2×10 -2 ~4×10 -2 Pa; the pressure of the argon gas is controlled at a standard atmospheric pressure; the current during smelting is 320-380A, and the entire smelting time is maintained at 600-840s. In order to ensure uniform mixing of the components, the ingot needs to be turned over and remelted 5 times to obtain a Zr-Nb-Ti-Ta alloy with uniform composition.
[0016] Preferably, in step (3), the atomizing nozzle pressure is 4.5-5.5 MPa, the rod rotation speed is 13 cm / min, and the induction coil melting current during the atomization process is 88-98 A.
[0017] Preferably, the powder size of the SLM selective laser melting additive manufacturing in step (4) is 20 to 90 μm.
[0018] Preferably, the heating rate before the insulation temperature in step (5) is 5°C / min.
[0019] The selective laser melting forming equipment for additive manufacturing of the present invention adopts MT150-T.
[0020] A high-strength and low-modulus biomedical zirconium alloy has the following organizational characteristics: columnar crystals and equiaxed crystals of β-Zr are used as a matrix, and ω phase is precipitated through a heat treatment process to achieve the purpose of enhancing tensile strength.
[0021] The application of the high-strength and low-modulus biomedical zirconium alloy in the preparation of human implants.
[0022] Preferably, the human implants include artificial joints, hip joints, dentures, and skull implants.
[0023] Compared with the prior art, the present invention has the following advantages and beneficial effects:
[0024] 1. Compared with traditional biomedical titanium alloys, the medical β-type zirconium alloy prepared by the present invention has a lower elastic modulus. At the same time, due to the heat treatment process, the ω phase is precipitated, making the alloy have higher strength (tensile strength 1076MPa) and lower elastic modulus (~83GPa). Compared with the Zr-10Nb-10Ti-2.5Ta alloy formed by additive manufacturing without heat treatment, the tensile strength is increased by 200MPa.
[0025] 2. The high-strength, low-modulus biomedical zirconium alloy formed by the additive manufacturing technology of the present invention has the characteristics of rapid heating and cooling of SLM, so the obtained structure has smaller grains than traditional casting alloys, and the fine grains produce a large number of dislocations, so it has better mechanical properties.
[0026] 3. The present invention provides a guiding idea for the precipitation of the second phase by heat treatment of zirconium alloys formed by additive manufacturing.
[0027] 4. The present invention adopts additive manufacturing, which can realize the forming of complex medical models compared to traditional casting processing methods, meet personalized design requirements, and can customize medical implants for patients.
[0028] 5. The selective laser melting technology used in the present invention can achieve near-net forming, improve material utilization, and thus save costs. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] Figure 1 The present invention is a flow chart of the preparation process;
[0030] Figure 2 The morphology of the high-strength and low-modulus biomedical zirconium alloy powder in Example 2 of the present invention;
[0031] Figure 3 This is a microstructure image of the high-strength and low-modulus biomedical zirconium alloy after heat treatment in Example 2 of the present invention;
[0032] Figure 4 This is a TEM bright field morphology image of the high-strength and low-modulus biomedical zirconium alloy after heat treatment in Example 2 of the present invention;
[0033] Figure 5 This is the tensile stress-strain diagram of the high-strength, low-modulus biomedical zirconium alloy after heat treatment in Example 2 of the present invention. DETAILED DESCRIPTION
[0034] In order to enable those skilled in the art to better understand the solutions of the present invention, the technical solutions in the embodiments of the present invention will be clearly and completely described below in combination with the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work should fall within the scope of protection of the present invention.
[0035] It should be noted that the terms "first", "second", etc. in the specification and claims of the present invention are used to distinguish similar objects, and are not necessarily used to describe a specific order or sequence. It should be understood that such applicable data can be interchanged where appropriate, so that the embodiments of the present invention described herein can be implemented in an order other than those described herein. In addition, the terms "including" and "having" and any variations thereof are intended to cover non-exclusive inclusions, for example, a process, method, system, product or device that includes a series of steps or units is not necessarily limited to those steps or units that are clearly listed, but may include other steps or units that are not clearly listed or inherent to these processes, methods, products or devices.
[0036] The present invention will be further described below in conjunction with specific embodiments.
[0037] The present invention provides a method for preparing a high-strength and low-modulus biomedical zirconium alloy. Figure 1As shown. In the present invention, by strictly controlling the content of each element, alloying is used to form an infinite solid solution with Nb and Ti elements and Zr, thereby achieving solid solution strengthening, which can effectively improve the strength of the zirconium alloy. At the same time, the Ta element has high biocompatibility and can be used as a human implant material. In addition, Nb, Ti, and Ta are all β-phase stabilizing elements, which can retain the high-temperature β-phase to room temperature, which is beneficial to reducing the elastic modulus of the alloy and improving the corrosion resistance and plasticity of the alloy. According to the binary phase diagram of zirconium alloy, the composition of the high-strength and low-modulus biomedical zirconium alloy is determined to be Zr77.5at.%, Nb 10at.%, Ti 10at.%, and Ta 2.5at.%.
[0038] Example 1
[0039] A method for preparing a high-strength and low-modulus biomedical zirconium alloy comprises the following steps:
[0040] (1) Alloy composition design: alloy components are prepared using sponge zirconium, sponge titanium, niobium blocks, and tantalum wire as raw materials.
[0041] (2) Alloy smelting: The Zr, Nb, Ti and Ta elements are proportioned according to the content of step (1), and the alloy is smelted in a water-cooled copper crucible non-consumable vacuum arc furnace. The current during smelting is 340A and the smelting time is 720s. After the smelting is completed, the crucible is cooled by circulating cooling water at the bottom to prepare alloy rods. In order to ensure that the ingot has a uniform composition and no obvious segregation, the ingot needs to be turned over and remelted 5 times, and finally the surface oxide layer is removed;
[0042] (3) Atomization powder making: The alloy rod is atomized by a rotating electrode induction gas atomization device. During atomization, the nozzle pressure is 5 MPa, the rod rotation speed is 13 cm / min, and the induction coil melting current during the atomization process is 91 A. The powder prepared by atomization is then sieved to obtain a spherical powder with a particle size range suitable for additive manufacturing.
[0043] (4) Additive manufacturing: Selective laser melting equipment was used for additive manufacturing to obtain medical zirconium alloy; key molding process parameters were laser power: 200W, scanning speed: 700mm / s, scanning spacing 0.08mm, scanning layer thickness 0.3mm, and oxygen content during the molding process was controlled at 400-600ppm. Due to the rapid heating and cooling characteristics of selective laser melting, the growth of grains was suppressed, thereby preparing zirconium alloy samples with fine or even ultrafine grain structures.
[0044] (5) Heat treatment: The Zr-10Nb-10Ti-2.5Ta zirconium alloy formed by selective laser melting is kept at 550°C for 3 hours to obtain a high-strength and low-modulus biomedical zirconium alloy. The heat treatment process promotes the dispersion and precipitation of the ω phase in the crystal, which is beneficial to improve the tensile strength of the alloy.
[0045] The density of the zirconium alloy formed in this embodiment within the processing parameter range is as high as 99.8%, which is almost fully dense. Its phase composition is based on β-Zr, and the average grain size is 33.42μm. The heat treatment process promotes the dispersion and precipitation of the second phase, and the ω phase is spherically distributed in the crystal with a size of 5 to 30nm.
[0046] The zirconium alloy parts manufactured by the method described in this embodiment are processed into standard tensile specimens, and the relevant mechanical properties are shown in Table 1. The tensile strength of this embodiment is 1043MPa, and the elastic modulus is ~85GPa. Compared with the Zr-10Nb-10Ti-2.5Ta alloy formed by additive manufacturing without heat treatment, the tensile strength is increased by 200MPa, and the elastic modulus is reduced by 25GPa compared with the traditional TC4 alloy. The hardness of the alloy after heat treatment is 352.4HV. Obviously, Example 1 has higher strength than the existing medical zirconium alloy implants for clinical application and can withstand larger loads in the human body. The lower elastic modulus can effectively reduce the "stress shielding" effect caused by the mismatch of elastic modulus, which ultimately leads to implant failure.
[0047] Table 1 Comparison of mechanical properties of conventional casting, selective laser melting, and selective laser melting-heat treatment
[0048] Preparation method Tensile strength / MPa Vickers hardness / HV Conventional Casting Processing 764 336 Selective Laser Melting 841 229 Selective Laser Melting-Heat Treatment 1043 352.4
[0049] Example 2
[0050] A method for preparing a high-strength and low-modulus biomedical zirconium alloy comprises the following steps:
[0051] (1) Alloy composition design: alloy components are prepared using sponge zirconium, sponge titanium, niobium blocks, and tantalum wire as raw materials.
[0052] (2) Alloy smelting: The Zr, Nb, Ti and Ta elements are proportioned according to the content of step (1), and the alloy is smelted in a water-cooled copper crucible non-consumable vacuum arc furnace. The current during smelting is 360A and the smelting time is 820s. After the smelting is completed, the crucible is cooled by circulating cooling water at the bottom to prepare alloy rods. In order to ensure that the ingot has a uniform composition and no obvious segregation, the ingot needs to be turned over and remelted 5 times, and finally the surface oxide layer is removed;
[0053] (3) Atomization powder making: The alloy rod is atomized by a rotating electrode induction gas atomization device. During atomization, the nozzle pressure is 5.5 MPa, the rod rotation speed is 13 cm / min, and the induction coil melting current during the atomization process is 96 A. The powder prepared by atomization is then sieved to obtain a spherical powder with a particle size range suitable for additive manufacturing.
[0054] (4) Additive manufacturing: Selective laser melting equipment was used for additive manufacturing to obtain medical zirconium alloy; key molding process parameters: laser power: 180W, scanning speed: 1050mm / s, scanning spacing 0.11mm, scanning layer thickness 0.3mm, and oxygen content in the molding process was controlled at 400-600ppm. Due to the rapid heating and cooling characteristics of selective laser melting, the growth of grains was suppressed, thereby preparing zirconium alloy samples with fine or even ultrafine grain structures.
[0055] (5) Heat treatment: The Zr-10Nb-10Ti-2.5Ta zirconium alloy formed by selective laser melting is kept at 600°C for 3 hours to obtain a high-strength and low-modulus biomedical zirconium alloy. The heat treatment process promotes the dispersion and precipitation of the ω phase in the crystal, which is beneficial to improve the tensile strength of the alloy.
[0056] High strength and low modulus biomedical zirconium alloy powder morphology Figure 2 As shown; the microstructure image of high-strength low-modulus biomedical zirconium alloy after heat treatment is shown Figure 3 As shown; TEM bright field morphology of high strength low modulus biomedical zirconium alloy after heat treatment Figure 4 As shown; the tensile stress-strain relationship of high-strength low-modulus biomedical zirconium alloy after heat treatment is as follows Figure 5 shown.
[0057] The density of the zirconium alloy formed in this embodiment within the processing parameter range is as high as 99.9%, which is almost fully dense. Its phase composition is based on β-Zr, and the average grain size is 30.21μm, which is smaller than that of Example 1. The heat treatment process promotes the dispersion and precipitation of the second phase, and the ω phase is spherically distributed in the crystal, with a size of 5 to 20nm.
[0058] The zirconium alloy parts manufactured by the method described in this embodiment are processed into standard tensile specimens, and the relevant mechanical properties are shown in Table 2. The tensile strength of this embodiment is 1076MPa, and the elastic modulus is ~83GPa. Compared with the Zr-10Nb-10Ti-2.5Ta alloy formed by additive manufacturing without heat treatment, the tensile strength is increased by 200MPa, and the elastic modulus is reduced by 27GPa compared with the traditional TC4 alloy. The hardness of the alloy after heat treatment is 353.2HV. Obviously, Example 2 has higher strength than the existing medical zirconium alloy implants for clinical application, and can withstand larger loads in the human body. The lower elastic modulus can effectively reduce the "stress shielding" effect caused by the mismatch of elastic modulus, which ultimately leads to implant failure.
[0059] Table 2 Comparison of mechanical properties of conventional casting, selective laser melting, and selective laser melting-heat treatment
[0060] Preparation method Tensile strength / MPa Vickers hardness / HV Conventional Casting Processing 764 336 Selective Laser Melting 867 232 Selective Laser Melting-Heat Treatment 1075.6 353.2
[0061] Example 3
[0062] A method for preparing a high-strength and low-modulus biomedical zirconium alloy comprises the following steps:
[0063] (1) Alloy composition design: alloy components are prepared using sponge zirconium, sponge titanium, niobium blocks, and tantalum wire as raw materials.
[0064] (2) Alloy smelting: The Zr, Nb, Ti and Ta elements are proportioned according to the content of step (1), and the alloy is smelted in a water-cooled copper crucible non-consumable vacuum arc furnace. The current during smelting is 380A and the smelting time is 760s. After the smelting is completed, the crucible is cooled by circulating cooling water at the bottom to prepare alloy rods. In order to ensure that the ingot has a uniform composition and no obvious segregation, the ingot needs to be turned over and remelted 5 times, and finally the surface oxide layer is removed;
[0065] (3) Atomization powder making: The alloy rod is atomized by a rotating electrode induction gas atomization device. During atomization, the nozzle pressure is 4.5 MPa, the rod rotation speed is 13 cm / min, and the induction coil melting current during the atomization process is 93 A. The powder prepared by atomization is then sieved to obtain a spherical powder with a particle size range suitable for additive manufacturing.
[0066] (4) Additive manufacturing: Selective laser melting equipment was used for additive manufacturing to obtain medical zirconium alloy; key molding process parameters were laser power: 250W, scanning speed: 900mm / s, scanning spacing 0.1mm, scanning layer thickness 0.3mm, and oxygen content during the molding process was controlled at 400-600ppm. Due to the rapid heating and cooling characteristics of selective laser melting, the growth of grains was suppressed, thereby preparing zirconium alloy samples with fine or even ultrafine grain structures.
[0067] (5) Heat treatment: The Zr-10Nb-10Ti-2.5Ta zirconium alloy formed by selective laser melting is kept at 650°C for 3 hours to obtain a high-strength and low-modulus biomedical zirconium alloy. The heat treatment process promotes the dispersion and precipitation of the ω phase in the crystal, which is beneficial to improve the tensile strength of the alloy.
[0068] The density of the zirconium alloy formed in this embodiment within the processing parameter range is as high as 99.8%, which is almost fully dense. Its phase composition is based on β-Zr, and the average grain size is 36.21μm. Compared with Examples 1 and 2, the energy density of this forming is increased, which increases the grain size. The heat treatment process promotes the dispersion and precipitation of the second phase, and the ω phase is distributed in the crystal in a spherical shape with a size of 7 to 33nm.
[0069] The zirconium alloy parts manufactured by the method described in this embodiment are processed into standard tensile specimens, and the relevant mechanical properties are shown in Table 3. The tensile strength of this embodiment is 1009MPa, and the elastic modulus is ~78GPa. Compared with the Zr-10Nb-10Ti-2.5Ta alloy formed by additive manufacturing without heat treatment, the tensile strength is increased by 130MPa, and the elastic modulus is reduced by 32GPa compared with the traditional TC4 alloy. The hardness of the alloy after heat treatment is 342.3HV. Obviously, Example 2 has higher strength than the existing medical zirconium alloy implants for clinical application, and can withstand larger loads in the human body. The lower elastic modulus can effectively reduce the "stress shielding" effect caused by the mismatch of elastic modulus, which ultimately leads to implant failure.
[0070] Table 3 Comparison of mechanical properties of conventional casting, selective laser melting, and heat treatment after selective laser melting
[0071] Preparation method Tensile strength / MPa Vickers hardness / HV Conventional Casting Processing 764 336 Selective Laser Melting 873 233 Selective Laser Melting-Heat Treatment 1009 342.3
[0072] The above contents are only for explaining the technical idea of the present invention and cannot be used to limit the protection scope of the present invention. Any changes made on the basis of the technical solution in accordance with the technical idea proposed by the present invention shall fall within the protection scope of the claims of the present invention.
Claims
1. A method for preparing a high-strength and low-modulus biomedical zirconium alloy, characterized in that: The steps include: (1) Alloy composition design: By controlling the content of each element and utilizing alloying, Nb and Ti elements form an infinite solid solution with Zr, thereby achieving solid solution strengthening and improving the strength of the zirconium alloy. At the same time, Ta element has high biocompatibility and is used as a human implant material. In addition, Nb, Ti, and Ta are all β-phase stabilizing elements, which are used to retain the high-temperature β-phase to room temperature, reduce the elastic modulus of the alloy, and improve the corrosion resistance and plasticity of the alloy. According to the binary phase diagram of zirconium alloy, the composition of the high-strength and low-modulus biomedical zirconium alloy is determined to be Zr 77.5at.%, Nb 10at.%, Ti 10at.%, and Ta 2.5at.%. According to the composition, the alloy components are prepared using sponge zirconium, sponge titanium, niobium blocks, and tantalum wires as raw materials; (2) Alloy smelting: The Zr, Nb, Ti and Ta elements are mixed according to the content in step (1), and the alloy is smelted in a water-cooled copper crucible non-consumable vacuum arc furnace. After smelting, the crucible is cooled by circulating cooling water at the bottom to prepare alloy rods; (3) Atomization powder making: The alloy rod is atomized using a rotating electrode induction gas atomization device to prepare zirconium alloy powder and perform screening to obtain spherical powder with a particle size range suitable for additive manufacturing; (4) Additive manufacturing: Selective laser melting equipment is used for additive manufacturing to obtain medical zirconium alloy; Key molding process parameters: laser power: 180-250W, scanning speed: 600-1100mm / s, scanning spacing 0.06-0.11mm, scanning layer thickness 0.3mm, oxygen content in the molding process is controlled at 400-600ppm; (5) Heat treatment: The Zr-10Nb-10Ti-2.5Ta zirconium alloy formed by selective laser melting is kept at 500-700°C for 1-4 hours to obtain a high-strength and low-modulus biomedical zirconium alloy.
2. The method for preparing the high-strength and low-modulus biomedical zirconium alloy according to claim 1, characterized in that: In step (2), the vacuum degree in the furnace is 2×10 -2 ~4×10 -2 Pa The pressure of the argon gas is controlled at a standard atmospheric pressure. The current during smelting is 320-380A, and the entire smelting time is maintained at 600-840s. In order to ensure uniform mixing of the components, the ingot needs to be turned over and remelted 5 times to obtain a Zr-Nb-Ti-Ta alloy with uniform composition.
3. The method for preparing the high-strength and low-modulus biomedical zirconium alloy according to claim 1, characterized in that: In step (3), the atomizing nozzle pressure is 4.5-5.5 MPa, the rod rotation speed is 13 cm / min, and the induction coil melting current during the atomizing process is 88-98 A.
4. The method for preparing the high-strength and low-modulus biomedical zirconium alloy according to claim 1, characterized in that: In step (4), the powder size of the SLM selective laser melting additive manufacturing is 20~90µm.
5. The method for preparing the high-strength and low-modulus biomedical zirconium alloy according to claim 1, characterized in that: The heating rate before the holding temperature in step (5) is 5°C / min.
6. A high-strength, low-modulus biomedical zirconium alloy, characterized in that: It is prepared by the preparation method described in any one of claims 1 to 5. The obtained high-strength and low-modulus biomedical zirconium alloy has the following organizational characteristics: columnar crystals and equiaxed crystals of β-Zr are used as the matrix, and ω phase is precipitated through a heat treatment process to achieve the purpose of enhancing tensile strength.
7. Use of the high-strength, low-modulus biomedical zirconium alloy according to claim 6 in the preparation of human implants.
8. The use of the high-strength and low-modulus biomedical zirconium alloy in the preparation of human implants according to claim 7, characterized in that: The human body implants include artificial joints, dentures, and skull implants.
